This new position paper will provide you with an analysis of the value created by digitalization at five key levels of pharma companies’ value chain:
The primary activities of pharma companies’ value chain are described and illustrated with practical examples.
As of today, the impact of digitalization varies significantly, depending on the considered activity.
“The question is not whether digitalization of pharma companies’ value chain is essential,
but how to best leverage digital technologies and innovations to boost business performance”